Fecal Immunochemical Testing to Screen for Colorectal Neoplasia

Publication Date: January 1, 2017
Last Updated: March 14, 2022

Recommendations

With 1-time application, FIT tests are approximately 80% sensitive for cancer detection and approximately 20%–30% sensitive for advanced neoplasia detection. To enhance advanced adenoma detection, repeated applications of FIT are required. Therefore, we recommend repeated testing (see later for details) to maximize the effectiveness of cancer detection and prevention with this modality. Individuals choosing FIT should understand the need for recurring testing and for colonoscopy to evaluate a positive FIT result. Programs to track cycles of testing are encouraged to facilitate completion. (1M)
700

Overview

Title

Fecal Immunochemical Testing to Screen for Colorectal Neoplasia

Authoring Organizations